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Abstract
Background: The loss of alveolar walls is a hallmark of emphysema. As fibroblasts play an important role in the maintenance
of alveolar structure, a change in fibroblast phenotype could be involved in the pathogenesis of this disease. In a previous study
we found a reduced in vitro proliferation rate and number of population doublings of parenchymal lung fibroblasts from patients
with emphysema and we hypothesized that these findings could be related to a premature cellular aging of these cells. In this
study, we therefore compared cellular senescence markers and expression of respective genes between lung fibroblasts from
patients with emphysema and control patients without COPD.
Methods: Primary lung fibroblasts were obtained from 13 patients with moderate to severe lung emphysema (E) and 15
controls (C) undergoing surgery for lung tumor resection or volume reduction (n = 2). Fibroblasts (8E/9C) were stained for
senescence-associated β-galactosidase (SA-β-Gal). In independent cultures, DNA from lung fibroblasts (7E/8C) was assessed for
mean telomere length. Two exploratory 12 k cDNA microarrays were used to assess gene expression in pooled fibroblasts (3E/
3C). Subsequently, expression of selected genes was evaluated by quantitative PCR (qPCR) in fibroblasts of individual patients
(10E/9C) and protein concentration was analyzed in the cell culture supernatant.
Results: The median (quartiles) percentage of fibroblasts positive for SA-β-Gal was 4.4 (3.2;4.7) % in controls and 16.0
(10.0;24.8) % in emphysema (p = 0.001), while telomere length was not different. Among the candidates for differentially
expressed genes in the array (factor ≥ 3), 15 were upregulated and 121 downregulated in emphysema. qPCR confirmed the
upregulation of insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-rP1 (p = 0.029, p = 0.0002), while expression of
IGFBP-5, -rP2 (CTGF), -rP4 (Cyr61), FOSL1, LOXL2, OAZ1 and CDK4 was not different between groups. In line with the gene
expression we found increased cell culture supernatant concentrations of IGFBP-3 (p = 0.006) in emphysema.
Conclusion: These data support the hypothesis that premature aging of lung fibroblasts occurs in emphysema, via a telomere-
independent mechanism. The upregulation of the senescence-associated IGFBP-3 and -rP1 in emphysema suggests that inhibition
of the action of insulin and insulin-like growth factors could be involved in the reduced in vitro-proliferation rate.
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Background
Lung fibroblasts from patients with emphysema show a
reduced proliferation rate [1,2], altered growth factor
response [3] and lower number of population doublings
in long-term culture [1]. Together with clinical observa-
tions, these findings lend support to the hypothesis that
premature aging of structural cells is involved in the
pathogenesis of emphysema. Senescent cells not only
loose their ability to divide and respond to mitogenic
stimuli but also display alterations in morphology and
metabolic profile [4]. This phenotype can be induced by
oxidative stress [5], in association with epigenetic changes
in gene expression [6,7]. As fibroblasts provide part of the
lung's structural support and matrix that is essential for its
integrity [8], a senescent phenotype could affect tissue
microbalance and structural maintenance of the lung. We
thus focused on lung fibroblasts as important players,
keeping in mind that it is unlikely that alterations found
in these cells are strictly limited to this type of structural
cell.
One well-known marker of cellular senescence is senes-
cence-associated  β-galactosidase (SA-β-Gal) [9,10]. Its
expression depends on confluence [11] and aged cells are
positive for SA-β-Gal most likely due to an increased lyso-
somal content [10].
Among the mechanisms implicated in cellular aging, the
telomere hypothesis [12] is based on the fact that tel-
omere length is reduced in each cell division. A length
below a critical value induces cell cycle exit and thereby
limits the cell's replicative capacity. Indeed, telomeres
shorten during aging of cultured fibroblasts [13] and their
initial length correlates with replicative capacity [14].
However, an unaltered telomere length would not dis-
prove the hypothesis of aging, as replicative senescence
can also be mediated by telomere-independent mecha-
nisms [4].
To elucidate further potential mechanisms, targets
selected from an exploratory 12 k cDNA array analysis
were reevaluated by quantitative PCR (qPCR), with
emphasis on genes related to proliferation and aging. We
focused on insulin-like growth factor-binding proteins
(IGFBP), as they might mediate between systemic and
local alterations in COPD. IGFBP-3 [15] and IGFBP-
related protein (rP)-1 (IGFBP-7) [16,17] are associated
with senescence, and IGFBP-5 is involved in regulating
lung matrix composition [18] and development [19]. It
was found to be downregulated with increasing age [20]
but upregulated in whole lung samples from severe
emphysema [21]. IGFBP-rP2 (CTGF, connective tissue
growth factor) and IGFBP-rP4 (Cyr61, cysteine-rich ang-
iogenic inducer 61) are also of interest in this respect [22].
To cover a broad mechanistic spectrum of further candi-
dates that are known to be implicated in cell cycle regula-
tion or senescence, we selected FOSL1 (fos-like antigen 1,
Fra-1), a family member of Fos transcription factors [23],
LOXL2 (lysyl oxidase-like 2), a member of the lysyl oxi-
dase (LOX) family [24], OAZ1 (ornithine decarboxylase
antizyme 1), an inhibitor of the ornithine decarboxylase
[25], and CDK4 (cyclin-dependent kinase 4).
Thus the aim of the present study was to further character-
ize the phenotype of primary parenchymal lung fibrob-
lasts in emphysema and to obtain further clues regarding
the hypothesis that premature cellular aging plays a role in
this disease. For this purpose we compared SA-β-Gal activ-
Table 1: Patients' characteristics (all patients, for data of subgroups see Results)
Control Emphysema
n1 5 1 3
Age yr 62 (54; 67) 64 (58; 70)
Sex m/f 10/5 13/0
BMI kg/m2 24.9 (24.3; 26.6) 22.4 (22.2; 23.9) *
VC %pred 101.7 (87.2; 110.5) 73.6 (71.6; 90.0) **
FEV1 %pred 94.7 (83.9; 106.3) 37.2 (33.5; 40.7) **
FEV1/VC %pred 99.0 (94.3; 104.2) 53.2 (44.6; 54.0) **
ITGV %pred 104.0 (90.2; 117.8) 181.0 (167.0; 222.3) **
RV L 2.12 (1.86; 2.52) 5.44 (4.53; 6.42) **
TLC L 6.47 (4.60; 7.05) 8.7 (8.02; 9.89) **
RV/TLC % 38.1 (32.6; 45.1) 64.1 (54.1; 67.8) **
Smoking history packyears 25 (20;40) 50 (40;70) *
COPD stage 0/I/II/III/VI 15/0/0/0/0 0/0/1/11/1
DT h 24.8 (21.7; 25.5) 31.2 (29.3; 40.9) **
The table shows median values and quartiles (in parentheses), *p < 0.05, **p < 0.01 regarding the difference between groups. BMI = body mass 
index, VC = vital capacity, FEV1 = forced expiratory volume in one second, ITGV = intra thoracic gas volume, RV = residual volume, TLC = total 
lung capacity, DT = doubling time (time needed for doubling of cell number) of parenchymal lung fibroblasts in culture. Predicted values were taken 
form ERS guidelines [36] stages of COPD according to GOLD guidelines http://www.goldcopd.com.Respiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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ity, telomere length, and the expression of a selected panel
of genes between lung fibroblasts from patients with
emphysema and control patients.
As a result we found that a higher proportion of fibrob-
lasts from patients with emphysema exhibited SA-β-Gal
activity and that these cells showed an increased expres-
sion of senecence-associated IGFBP-rP1 and IGFBP-3
genes and of IGFBP-3 protein, whereas no difference in




Primary lung fibroblasts from 13 patients with moderate
to severe lung emphysema and 15 patients without clini-
cal, morphological or functional signs of COPD (control)
were included (Table 1). All patients were undergoing sur-
gery for lung tumor resection except for two undergoing
volume reduction surgery. All patients were smokers
except for two patients without COPD. The diagnosis of
emphysema took into account all available information,
including patients' history, symptoms, chest X-ray (11C,
10E) or CT (7C, 10E), histology, lung function compris-
ing expiratory flow-volume curves, resistance loops and
plethysmographic lung volumes, as well as diffusion
capacity for carbon monoxide (3C, 5E). The study was
approved by the local Ethics Committee and all patients
gave their written informed consent.
Lung fibroblasts
Only lungs from patients without visible/palpable lung
metastases were used. Pleura-free parenchymal specimens
were excised after careful macroscopic evaluation from
peripheral areas of the lobe as far away from the tumor
site as possible. The tissue was immediately transferred
into explant culture (Dulbeccos Modified Eagles Medium,
10% fetal calf serum) as described previously [1]. As it was
necessary to ensure comparable and low passage num-
bers, only limited amounts of cells were available in each
patient. Therefore the different assays comprised different,
though overlapping, subgroups of patients. Proliferation
and population doublings (PDL) were measured as previ-
ously described [1]. Fibroblasts were transferred to 24-
well dishes and cell numbers determined manually after
24, 48, 72 and 96 h, while the maximum PDL was deter-
mined after weekly passaging until the harvested cell
numbers dropped below the initially seeded number of
100.000.
Staining for Senescence-associated β-Galactosidase (SA-β-
Gal)
A total of 10.000–15.000 fibroblasts were transferred
onto glass cover slides (18 mm2). After culture for 24 h in
6-well plates under standardized conditions (37°C, 5 %
CO2), staining for SA-β-Gal activity at pH 6.0 was per-
formed (Cell Signaling Technologies, Beverly, MA, USA).
Cells positive for the blue stain were counted under visible
light, while counter-staining with DAPI enabled the deter-
mination of cell number under UV light. To assess sensi-
tivity, 6 independent primary fibroblast cultures were
stained in each of three consecutive passages. The propor-
tion of cells positive for SA-β-Gal showed a median (IQR)
increase of 5.5 (16.3) % per passage. Thus all staining
experiments were performed in passage 4–5.
Telomere length – Terminal restriction fragment (TRF) 
length analysis
Cryopreserved cells were thawed, cultured and harvested
in passage 2–3 as previously described [1]. DNA was
extracted (DNeasy, Qiagen, Hilden, Germany) and
digested using RSA I / Hinf I (TeloTAGGG Telomere
Length Assay, Roche, Mannheim, Germany). After electro-
phoretic separation of fragments in 0.8 % agarose gel and
blotting (0.2 µm nitrocellulose, 20 × SSC buffer over-
night), a DIG-labeled, telomere-specific probe was
hybridized to the membrane, coupled with an anti-DIG-
alkaline peroxidase conjugate and visualized by chemilu-
minescence. Mean TRF length was calculated as the sum
over the chemiluminescence intensity at each position of
the blot, divided by the sum of ratios of intensity at each
position to TRF length at that position.
Table 2: Primer sequences used for qPCR
HUGO ID 5'- sense primer- 3' 5'- antisense primer – 3' product (bp) Sequence ID
PBGD [26] CACACAGCCTACTTTCCAAGC TTCAATGTTGCCACCACACT 155 NM_000190.2
IGFBP-3 CCTGCCGTAGAGAAATGGAA GAAGGGCGACACTGCTTT 127 NM_000598
IGFBP-5 GAGCAAGTCAAGATCGAGAGAGA GAAAGTCCCCGTCAACGTA 463 M65062
IGFBP-rP1 CTGCGAGCAAGGTCCTTCCATA CAGGTTGTCCCGGTCACCA 184 NM_001553
CTGF [22] CCTGCAGGCTAGAGAAGCAGA TGCACTTTTTGCCCTTCTTAATGT 90 NM_001901
Cyr61 ACACCAAGGGGCTGGAATG TGGGGACACAGAGGAATG 193 AF31385
LOXL2 CGGAGGATGTCGGTGTGGT GCTTGCGGTAGGTTGAGAGG 150 NM_002318
OAZ1 AGGTGGGCGAGGGAATAG ATGCGTTTGGCGTCTGTG 150 U09202
FOSL1 CAGGCGGAGACTGACAAA GGGAAAGGGAGATACAAGGT 217 NM_005438
CDK4 TGCAGTCCACATATGCAACAC CAGCCCAATCAGGTCAAAG 137 M14505Respiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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Gene expression analysis
For exploratory cDNA array analysis fibroblasts were
thawed and cultured up to passage 3. Three fibroblast
lines from patients with emphysema with a low prolifera-
tion rate and three lines from controls with a high prolif-
eration rate as compared to the mean within their group
were selected for this experiment. Cells were harvested,
immediately frozen and shipped on dry ice for cDNA
array analysis (11.835 genes; Atlas™ Plastic Human 12 k
Microarray, 634811, Custom Service, BD Biosciences
Clontech, Palo Alto, CA, USA). Fibroblasts of each group
were pooled, RNA extracted, its quality confirmed by the
Agilent Bioanalyzer™ and radio-labeled cDNA probes
were hybridized to one array per group. After global nor-
malization and additional correction for GAPDH and β-
actin, gene expression was compared between groups
(http://www.ncbi.nlm.nih.gov/projects/geo/, GSE 3510).
Expression of selected genes was further analyzed by
qPCR in independent cultures. Fibroblasts were thawed,
cultured up to passage 3; harvested and stored frozen until
RNA isolation (RNeasy, Qiagen). A second dish of each
line was cultured without fetal calf serum for 2 days prior
to harvesting to obtain culture medium for the analysis of
total protein and IGFBP-3 concentrations. RNA was tran-
scribed to cDNA using the Qiagen Omniscript-Kit. One
primer (sense or anti-sense) was designed intron-span-
ning using the Primer3 internet-based program http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi.
Primer pairs were checked for specific product length by 2
% agarose gel electrophoresis. Primer sequences are listed
in Table 2. cDNA of each individual patient was used for
quantification by Lightcycler real-time PCR (LC1.0 or
LC2.0, Roche) as published previously [26]. Gene expres-
sion was normalized by external calibrators for target and
reference, as well as by the individual PBGD (porpho-
bilinogen deaminase) expression using RelQuant soft-
ware V1.01 (Roche).
IGFBP-3 protein was analyzed by ELISA (human IGFBP3
Duoset, R&D Systems, Wiesbaden Germany) and total
protein by the BCA method [27].
Data analysis
Owing to the skewed distribution of most variables,
median values and quartiles or interquartile ranges (IQR)
were chosen for description. Accordingly, the Mann-Whit-
ney U-test was employed for the comparison of groups
and the Spearman rank correlation coefficient for assess-
ing the relationship between variables. P-values of less
than 0.05 were considered statistically significant.
Results
Senescence-associated β-Galactosidase
The subgroups of patients, in which lung fibroblasts were
analyzed for SA-β-Gal differed statistically significantly
regarding all indices listed in Table 1, except for BMI,
smoking history and age (emphysema: n = 8, median
(IQR) age 62 (16) yr, FEV1 36 (13) %pred; control: n = 9,
age 65 (13) yr, FEV1 102 (20) %pred). Median (quartiles)
doubling time (DT) in passage 2 was 30.7 (28.4; 36.1) h
in emphysema and 24.8 (22.8; 25.8) h in control (p =
0.004). The number of population doublings (PD) after
thawing of cells was 1.8 (0.5; 3.2) and 4.2 (2.9; 5.7) (p =
0.020).
In emphysema the percentage of fibroblasts staining pos-
itive for SA-β-Gal was 16.0 (10.0; 24.8) % compared to
4.4 (3.2; 4.7) % in control samples (p = 0.001, Figure 1).
Correspondingly, there was a positive correlation between
the proportion of cells positive for SA-β-Gal and DT (rS =
0.79, p = 0.0003) and a negative correlation with PD (rS =
-0.68, p = 0.004).
Telomere length
The two subgroups of patients whose DNA was analyzed
for telomere length differed significantly regarding all
indices listed in Table 1, but not for smoking history and
age (emphysema: n = 7, age 62 (13) yr, FEV1 34 (13) %
pred; control: n = 8, age 66 (15) yr, FEV1 105 (20) %
pred). The median (quartiles) doubling time (DT) in pas-
Distribution of the percentage of cells staining positive for  SA-β-Gal in control patients and patients with emphysema in  passage 4–5 (dotted line: median value) Figure 1
Distribution of the percentage of cells staining positive for 
SA-β-Gal in control patients and patients with emphysema in 
passage 4–5 (dotted line: median value).Respiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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sage 2 was 30.6 (27.4; 33.6) h in emphysema and 24.9
(22.5; 25.6) h in control patients (p = 0.011).
Terminal restriction fragment (TRF) length did not differ
significantly between groups, values being 9.3 (8.6; 10.0)
kbp in emphysema and 8.9 (8.3; 9.4) kbp in control (Fig-
ures 2 and 3). To assess reproducibility, the assay was
repeated in 5 patients per group using the same batch of
DNA; the correlation coefficient between these determi-
nation was rS = 0.75 (p = 0.013).
Gene expression analysis
For array analysis, fibroblasts of two groups (n = 3 each;
emphysema: age 64 (15) yr, FEV1 39 (13) %pred; control:
age 67 (1) yr, FEV1 92 (60) %pred) were used. DT in pas-
sage 2 were 40.9, 42.1 and 47.8 h in the individuals with
emphysema, and 22.8, 21.2 and 25.5 h in control
patients.
There was a factor ≥ 2 difference in expression between
groups in 979 genes. To render the conclusions to be
drawn for subsequent analysis as safe as possible without
missing too many candidates, we then selected genes with
a difference of factor ≥ 3, whereby at the same time signal
intensities on both arrays were ≥ 2 times the 75-percentile
of the intensity distribution of the respective arrays. Fif-
teen genes were thus found to be upregulated in fibrob-
lasts of emphysema, among them IGFBP-rP1 (4.9-fold),
LOX (3.3-fold), LOXL2 (3.9-fold) and TIMP3 (3.0-fold),
whereas 121 genes were downregulated, among them
CDK4 (6.3-fold), FOSL1 (4.8-fold), OAZ1 (6.7-fold) and
IGFBP-5 (5.3-fold).
In order to check these results, gene expression analysis
was subsequently performed by qPCR in fibroblasts (pas-
sage 2 or 3) of individual patients of two groups of
patients (emphysema: n = 10, age 66 (12) yr, FEV1 40 (12)
%pred; control: n = 9, age 65 (8) yr, FEV1 98 (19) %pred).
The two groups differed significantly in all variables listed
in Table 1, except for BMI and age. The median (quartiles)
DT in passage 2 was 31.2 (29.3; 40.9) h in emphysema
and 24.8 (21.7; 25.4) h in control patients (p = 0.001).
Southern blot of terminal telomere restriction fragments (derived from of Rsa I/Hinf I digestion of DNA samples) detected by  chemiluminescence with a DIG-labeled telomeric probe in combination with anti-DIG-alkaline phosphatase (AP) secondary  antibody and CDP-star-AP© substrate Figure 2
Southern blot of terminal telomere restriction fragments (derived from of Rsa I/Hinf I digestion of DNA samples) detected by 
chemiluminescence with a DIG-labeled telomeric probe in combination with anti-DIG-alkaline phosphatase (AP) secondary 
antibody and CDP-star-AP© substrate. Panel A: Samples from 8 control patients (2 separate gels with molecular weight mark-
ers). Panel B: Samples from 7 patients with emphysema (2 separate gels with molecular weight markers)Respiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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No significantly different gene expression was observed by
qPCR regarding IGFBP-5, IGFBP-rP2 and -rP4, FOSL1,
LOXL2, OAZ1 and CDK4 (Table 3). Regarding IGFBP-3
and IGFBP-rP1, however, expression was significantly
higher in emphysema compared to control (Figure 4A/B,
Table 3).
In culture supernatants collected after 2 days of culture
without fetal calf serum, IGFBP-3 was detectable in 8 sam-
ples of patients with emphysema and in 9 control sam-
ples. After normalizing for the amount of total protein,
the median (quartiles) concentration of IGFBP-3 was
1619.6 (1024.1;2937.0) pg/mg protein in emphysema
and 505.8 (288.9;779.7) pg/mg protein in controls (p =
0.006).
Discussion
In the present study we found an increased staining for
SA-β-Gal and a qPCR-confirmed upregulation of senes-
cence-associated IGFBP-3 and IGFBP-rP1 in cultured pri-
mary parenchymal lung fibroblasts from patients with
emphysema; this was supplemented by detection of
higher protein levels of IGFBP-3. A comprehensive explor-
atory microarray analysis suggested that more genes were
down- than upregulated in emphysema, though a number
of differences could not be confirmed in qPCR. Taken
together with the already known reduction in prolifera-
tion rate and capacity, these findings provide further evi-
dence for a senescent phenotype of lung fibroblasts in
emphysema, in line with the hypothesis, that premature
aging of these cells is one of the relevant pathogenetic fac-
tors. As mean telomere length was unaltered, the senes-
cent phenotype is more likely to be mediated by telomere-
independent mechanisms.
Previous studies already demonstrated that lung fibrob-
lasts from patients with emphysema exhibited a reduced
proliferation rate and capacity in vitro [1,2]. An increase
over time in the proportion of senescent, cell cycle-
arrested cells could well be a contributor to tissue destruc-
tion. It seems conceivable that such deficiencies favour the
onset of emphysematous lesions, and indeed such altera-
tions have been found in senescence-accelerated mice
[28]. To check this hypothesis, we first assessed the pro-
portion of cells staining positive for SA-β-Gal, which is
considered as a marker of cellular senescence [9]. For this
assay we compared the staining between groups after
comparable culture times in vitro, as a rise in the percent-
age of SA-β-Gal positive cells can also be observed during
aging of cells in culture.
Telomere length, an important marker of cellular aging,
which represents a mitotic clock counting down in aging
cells, was similar in emphysema and controls. The assay
employed is an established procedure and has been suc-
cessfully used to reveal, for example, shorter telomere
lengths in lymphocytes of smokers [29]. The validity of
our data was indicated by the similar pattern observed in
the duplicate determinations, as well as by the fact that
telomere length was close to previously reported values
[13]. It might be argued that fibroblasts in emphysema
underwent more replications in vivo due to the need for
repair of tissue damage and therefore should have shorter
telomeres. The characteristics of cell proliferation curves
[1] suggest that fibroblasts from emphysema display rep-
licative senescence about 6 population doublings earlier
than controls. Assuming a shortening by about 50 bp in
each fibroblast replication [13], this difference would cor-
respond to telomeres being about 300 bp shorter in
emphysema compared to controls. In opposite to this,
mean telomere length as measured in the present study
was 400 bp greater. This implies a difference in length of
up to 700 bp contra hypothesis which renders it unlikely
that shortening of telomeres explained the difference in
Table 3: Results of gene expression analysis
Target gene cDNA array Emphysema/
Control
qPCR Controls qPCR Emphysema p-value
IGFBP-3 1.3 0.38 (0.15; 0.40) 0.82 (0.66; 1.36) 0.024*
IGFBP-5 0.19 115.0 (60.5; 161.0) 73.6 (49.0; 159.0) 0.51
IGFBP-rP1 (IGFBP-7) 4.87 4.25 (2.67; 5.59) 9.6 (6.77; 12.4) 0.002**
IGFBP-rP2 (CTGF) n.d. 2.97 (1.68; 4.25) 4.40 (3.86; 4.99) 0.070
IGFBP-rP4 (Cyr61) 0.84 258 (222; 329) 198 (185; 322) 0.57
LOXL2 3.88 1.27 (0.73; 1.79) 1.41 (1.22; 1.92) 0.63
OAZ1 0.15 0.22 (0.17; 0.25) 0.18 (0.18; 0.25) 0.96
FOSL1 0.21 0.89 (0.63; 1.16) 1.00 (0.78; 1.34) 0.57
CDK4 0.16 0.91 (0.58; 1.18) 0.73 (0.53; 0.78) 0.63
The cDNA array column gives the differential gene expression in the exploratory 12 k array experiment as ratio of emphysema to control. qPCR 
columns give the gene expression of the target gene relative to PBGD for control patients and patients with emphysema. These values are the 
median values (IQR) of the normalized ratios as derived from RelQuant software. They were additionally corrected by using ratios of qPCR 
calibrators. P-values refer to the comparison of qPCR results between the two groups and were calculated by the Mann-Whitney U-test. *p < 0.05, 
**p < 0.01, n.d. not determined.Respiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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fibroblast phenotypes. This is true even though the scatter
was large and the number of patients investigated was
limited. In fact, a statistical analysis showed a less than 5
% probability of obtaining the observed result if the
hypothesis of shortened telomeres in emphysema was
true. In addition we would like to note that the experi-
ments were performed in early passages. Thus it seems
unlikely that the higher in vitro proliferation rate of con-
trols diminished a potential difference to an extent, that it
was even reversed into the opposite.
This suggests the presence of telomere-independent repli-
cative senescence which is a well-known phenomenon
potentially involving a variety of pathways, including p16
[4,30]. On the basis of this, it does not seem likely that tel-
omere length was the major determinant of the observed
alterations in emphysema. It certainly would not explain
the differences in proliferation rate, SA-β-Gal staining and
gene or protein expression that occurred at comparable
telomere lengths.
Two cDNA arrays were used to find hints on differentially
expressed genes under baseline culture conditions. mRNA
of fibroblasts from patients typical of their group was
pooled and analyzed. Based on the results and a compre-
hensive literature study, the expression of selected genes
was then reevaluated in independent cultures from indi-
vidual patients. As the available cDNA was limited, we
focused on a small number of genes associated with senes-
cence and cell cycle, which appeared interesting or novel
with regard to the pathogenesis of emphysema. Special
attention was paid to using only fibroblasts from cultures
with a reproducible proliferation rate to ensure compara-
bility with previous results.
Among the genes that were most upregulated on the array
was IGFBP-rP1, whose expression is known to increase
during senescence [17]. This family of compounds
appeared of particular interest, as it might also provide a
bridge between local and systemic effects in COPD via
insulin-related pathways, similar to IGFBP-3 and -5. For
IGFBP-3 and IGFBP-rP1 the upregulation in emphysema
was confirmed by qPCR. Furthermore, increased concen-
trations of IGFBP-3 were detected in cell culture superna-
tants of fibroblasts from patients with emphysema. In the
qPCR analysis there was also a trend (p = 0.07) towards
upregulation of IGFBP-rP2, which had been previously
described as overexpressed in lung fibroblasts from
emphysema, together with IGFBP-rP4 [22]. We believe
that the facts that these authors studied patients with
more severe emphysema, as well as differences in method-
ology are responsible for the differences between the find-
ings.
The upregulation of IGFBP-3 and -rP1 can be taken as fur-
ther evidence for a senescent phenotype in emphysema.
As these proteins interact with mitogenic compounds
such as insulin-like growth factor I and II (IGF-I, II) or
insulin, an active role for IGFBPs in senescence might well
be assumed. Both IGF-I and -II are produced by interstitial
mesenchymal cells, epithelial cells and macrophages
within the lung, as known from studies in lung fibrosis,
and can regulate cell proliferation, especially in fibrob-
lasts [31]. Stimulation of the IGF-I receptor by IGF-I, IGF-
II [32] or insulin [33] can promote cell division, possibly
in synergy with EGF/EGFR and/or TGF-α [34]. The inter-
action of IGF-I, -II and insulin with their receptors is
largely regulated by IGFBPs and their related proteins
[32]. Specifically, elevated mRNA [15,30] or protein levels
of IGFBP-3 were found in late passage/senescent fibrob-
lasts [15] and IGFBP-3 is capable of interacting with IGF-
I [32]. IGFBP-rP1 can inhibit the growth of cancer cells via
a senescence-like mechanism, associated with SA-β-Gal
staining [16]. IGFBP-rP1 was also found upregulated in
senescent human mammary epithelial cells [17]. Through
binding to insulin it can prevent signal transduction
towards proliferation. Though the picture regarding the
insulin and IGF system is known to be very complex and
data are not always consistent, these findings and our
Distribution of mean terminal telomere restriction fragment  (TRF) lengths in control patients and patients with emphy- sema (dotted line: median value) Figure 3
Distribution of mean terminal telomere restriction fragment 
(TRF) lengths in control patients and patients with emphy-
sema (dotted line: median value).Respiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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results suggest that this system is involved in lung emphy-
sema. It is also important to note that we observed the dif-
ferences in fibroblast phenotype after several weeks in
culture, indicating that these were neither transient nor
dependent on the inflammatory environment in situ. It
does not seem far-fetched to assume the persistence of
alterations being at least partially due to epigenetic fac-
tors.
In performing the qPCR we additionally covered a
number of genes of diverse pathways that could be altered
in emphysema or cellular senescence. LOXL2 seemed of
interest as involved in cross-linking collagens and elastin
[24]; it has been found upregulated in fibroblasts in repli-
cative as well as stress-induced premature senescence [30].
Overproduction of the ornithine decarboxylase (ODC)
regulatory protein ODC-antizyme OAZ1 has been shown
to correlate with cell growth inhibition in a variety of cell
types [25]. This gene was included just because the down-
regulation in emphysema as indicated by the array would
argue against our hypothesis. As a key member of cell
cycle-associated factors, CDK4 was included, since there is
evidence for a downregulation in senescent cells [35]. In
addition, FOSL1 is known to be involved in proliferation
and can be upregulated by cigarette smoke [23]. None of
these genes turned out to be differentially regulated
between emphysema and control patients according to
qPCR. This does not render them irrelevant but puts addi-
tional emphasis on the findings regarding IGFBP-rP1 and
-3, which showed reproducible and meaningful differ-
ences between groups. In addition, IGFBP-3 levels were
elevated in supernatants of fibroblast from emphysema.
These experiments were performed in the absence of fetal
calf serum to avoid contributions from the serum.
Although serum starvation itself could increase the
amount of IGFBP-3 [15], the fact remains that this would
have affected both groups. Due to the larger proliferation
rate of control fibroblasts a higher total protein concentra-
tion was present in the supernatant. To reveal the relative
production of IGFBP-3 we therefore normalized to total
protein levels.
Due to the limited amount of cells available, it was not
possible to perform all investigations in fibroblasts from
the same group of patients. We ensured, however, that the
groups compared were adequate in each case, by showing
Relative expression of target genes obtained by qPCR in control patients and patients with emphysema Figure 4
Relative expression of target genes obtained by qPCR in control patients and patients with emphysema. Data points represent 
normalized ratios of gene expression relative to PBGD and corrected for qPCR calibrators (dotted line: median value). Values 
are expressed on a log-scale. Panel A: IGFBP-3 expression, Panel B: IGFBP-rP1 expressionRespiratory Research 2006, 7:32 http://respiratory-research.com/content/7/1/32
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that they differed not only with respect to key patients'
characteristics but also in fibroblast proliferation rates, as
shown previously [1]. The use of different independent
cultures, especially for gene expression analysis, thus
involved true replicate culture, not just replicate analysis
of the same RNA sample. This might well be the cause for
the differences between the findings of the exploratory
microarray analysis and the qPCR. On the other hand, the
fact that IGFBP-3 and -rP1 were upregulated in both anal-
yses and independent cultures, probably gives additional
weight to this result.
It has been suggested, that replicative senescence of dip-
loid cells in culture could be due to inadequate growth
conditions [5]. Taking into account this, it could be
argued, that our observations were at least partially the
result of differences in the ability to handle oxidative
stress in vitro. To resolve this issue, it would be helpful to
detect senescence markers in fibroblasts of histological
samples. Such analyses are, however, severely handi-
capped by the lack of fibroblast-specific antibodies. In
addition, functional analyses are not possible in these
cells without growing them in culture, and single-cell PCR
requires amplification of mRNA which is an additional
source of error. Thus we infer that, even if cell culture con-
ditions should have been involved in our study, the
present data provide evidence that a different phenotype
of fibroblasts exists in lung emphysema. Such a different
phenotype might well be present in other cells types, too,
and is likely to involve epigenetic alterations. The pres-
ence of such persistent, programmed alterations might be
of considerable importance for all attempts directed
towards alveolar regeneration in patients with lung
emphysema.
Conclusion
In conclusion, our data support the view that primary
parenchymal lung fibroblasts from patients with emphy-
sema show a senescent phenotype, which does not seem
to be based on a reduction of telomere length. Instead, the
upregulation of the senescence-associated IGFBP-3 and
IGFBP-rP1 suggests that a change in the response to
mitogenic and metabolic stimuli such as IGF-I, -II and
insulin is involved in the previously found reduced prolif-
eration rate in culture.
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